Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,017Revenue $M42.1Net Margin (%)-13.5Altman Z-Score0.5
Enterprise Value $M935EPS $-0.7Operating Margin %-5.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-6.5Pre-tax Margin (%)-13.5Higher ROA y-yY
Price/Book20.010-y EBITDA Growth Rate %-8.3Quick Ratio4.4Cash flow > EarningsY
Price/Sales21.55-y EBITDA Growth Rate %-28.2Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-3.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M141ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYFirst Eagle Investment 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.28)
$ 7.21216%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 7.21216%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 7.21222%New holding22,400
ARRYFirst Eagle Investment 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 7.21167%Add 150.00%250,000
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 7.21167%Sold Out0
ARRYFirst Eagle Investment 2011-03-31 Buy $2.7 - $3.29
($3)
$ 7.21140%New holding100,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 7.21140%New holding14,400
ARRYFirst Eagle Investment 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 7.21139%Sold Out0
ARRYFirst Eagle Investment 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 7.21111%Reduce 54.96%450,000
ARRYFirst Eagle Investment 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 7.21228%Add 62.96%999,132
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAUM CHARLES MDirector 2015-05-08Sell25,000$7.38-2.3 view
LEFKOFF KYLEDirector 2015-03-03Sell70,000$8-9.88 view
Robbins Andrews RSVP, Commercial Operations 2015-03-02Sell21,576$8.25-12.61 view
Squarer RonCEO 2015-03-02Sell40,000$8.25-12.61 view
BVF PARTNERS L P/IL10% Owner 2014-06-25Sell0$0-12.61 view
MOORE JOHN RVP, General Counsel 2013-11-29Sell11,666$5.7924.53 view
MOORE JOHN RVP, General Counsel 2013-11-13Sell200$5.7924.53 view
Ratcliffe LiamDirector 2013-09-27Sell1,125,728$620.17 view
Ratcliffe LiamDirector 2013-09-16Sell1,673,172$6.0818.59 view
Ratcliffe LiamDirector 2013-09-06Sell577,286$5.7924.53 view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
comment on ARRY Mar 02 2013 
Re: ARRY Aug 29 2011 
Drug Penny Stock Aug 23 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 

More From Other Websites
One Of Mark Lampert’s Small-Cap Biotech Picks Has Returned 84% This Year And It’s Not Done Yet Jun 10 2015
ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jun 02 2015
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 01 2015
Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential... Jun 01 2015
Put sale sees Array holding gains Jun 01 2015
Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting May 28 2015
Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference May 26 2015
Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference May 26 2015
Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS... May 18 2015
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 May 18 2015
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2015 On May 4, 2015 May 18 2015
ARRAY BIOPHARMA INC Financials May 15 2015
10-Q for Array BioPharma, Inc. May 10 2015
4 Speculative Biotechs With Huge Analyst Targets May 09 2015
Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS... May 07 2015
ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report May 07 2015
Is Isis just what the doctor ordered? May 06 2015
Array BioPharma (ARRY) Looks Good: Stock Rises 13.1% - Tale of the Tape May 05 2015
ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 04 2015
What Is Really Driving Array Higher May 04 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK